Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer (Prostate Cancer and Prostatic Diseases, 2023)

(untitled) - Jones, RH; Fizazi, K; James, ND; Tammela, TL; Matsubara, N; Priou, F; Beuzeboc, P; Lesimple, T; Bono, P; Kataja, V; Garcia, JA; Protheroe, A; et al.